A little-known Nasdaq-listed drugmaker plans to invest $100M in litecoin, appoints Charlie Lee to its board and names GSR as ...

MEI Pharma (NASDAQ:MEIP) has launched a $100 million Litecoin (CRYPTO: LTC) treasury program, backed by Titan Partners Group and ...

Attention remains on large-cap tokens on Friday as crypto bills’ approval fueled crypto rallies. While Ethereum steadied above $3,600, Litecoin surpassed the $100 psychological zone. LTC gained more ...

“This initiative represents the first time a public company is aligning its treasury strategy with Litecoin at an institutional level,” said Joshua Riezman, US Chief Strategy Officer, GSR. “It ...

MEI Pharma raises $100 million to buy Litecoin, boosting stock value and signaling confidence in LTC's future growth.

MEI Pharma commits $100M to Litecoin with Charlie Lee joining its board, signaling major institutional interest in LTC.

MEI Pharma announces a $100 million private placement to adopt Litecoin as its primary treasury reserve asset.

MEI Pharma, a publicly traded pharmaceutical company, closed a $100 million private placement to turn itself into a litecoin ...

MEI Pharma unveils bold $100M Litecoin treasury plan with Titan, GSR, Litecoin Foundation, expanding altcoin adoption beyond ...

Litecoin price prediction chatter has returned with force after LTC surged 23% in a single day, hitting $119, its highest ...

How companies like MicroStrategy and SharpLink are using crypto treasury strategies to reshape corporate finance with bitcoin ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange Business Wire 17 mins ago ...